FCM
FPRX

Farallon Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Farallon Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-501,618
Closed -$18.9M – 393
2021
Q1 		$18.9M Buy
501,618
+101,618
+25% +$3.83M 0.09% 106
2020
Q4 		$6.8M Buy
+400,000
New +$6.8M 0.04% 112